Table 1.
Patients’ signs and symptoms at baseline, after 3 and 5 days of treatment with monotherapy and combined therapy
| Day | Rhinorrhea [N (%)] | Redness of the nasal mucosa [N (%)] | Nasal blockage [N (%)] | Hyperplasia [N (%)] | Sum score [N (%)] | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Xylometazoline | Xylometazoline + dexpanthenol | Xylometazoline | Xylometazoline + dexpanthenol | Xylometazoline | Xylometazoline + dexpanthenol | Xylometazoline | Xylometazoline + dexpanthenol | Xylometazoline | Xylometazoline + dexpanthenol | |
| 0 | 3 (3.95) | 7 (9.33) | 4 (5.26) | 4 (5.33) | 1 (1.32) | 1 (1.33) | 4 (5.26) | 1 (1.33) | 0 (0.00) | 0 (0.00) |
| 3 | 16 (21.05) | 55 (73.33) | 3 (3.95) | 59 (78.67) | 22 (28.95) | 60 (80.00) | 22 (28.95) | 53 (70.67) | 0 (0.00) | 6 (8.00) |
| 5 | 39 (51.32) | 61 (81.33) | 27 (35.53) | 66 (88.00) | 49 (64.47) | 71 (94.67) | 41 (53.95) | 67 (89.33) | 1 (1.32) | 35 (46.67) |